World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 17 October 2012
Main ID:  NCT00635700
Date of registration: 06/03/2008
Primary sponsor: Yale University
Public title: Ziprasidone in the Psychosis Prodrome ZIP
Scientific title: Ziprasidone vs Placebo in the Prevention of Psychosis Among Symptomatic Adolescents and Young Adults at Prodromal Risk
Date of first enrolment: March 2008
Target sample size: 80
Recruitment status: Recruiting
URL:  http://clinicaltrials.gov/show/NCT00635700
Study type:  Interventional
Study design:  Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment  
Countries of recruitment
Canada United States
Contacts
Name:   Scott W Woods, MD
Address: 
Telephone: 203 074 7038
Email: scott.woods@yale.edu
Affiliation: 
Name:   Scott W Woods, MD
Address: 
Telephone:
Email:
Affiliation:  Yale University
Key inclusion & exclusion criteria

Inclusion Criteria:

- SIPS criteria for psychosis prodrome

- clinically referred

Exclusion Criteria:

- prolonged QTc

- history of syncope



Age minimum: 16 Years
Age maximum: 40 Years
Gender: Both
Health Condition(s) or Problem(s) studied
Psychosis Prodrome
Intervention(s)
Drug: placebo
Drug: ziprasidone
Primary Outcome(s)
conversion to psychosis [Time Frame: 6 months]
Secondary Outcome(s)
improvement SOPS total score [Time Frame: 8 weeks]
Secondary ID(s)
0801003386
IIR GA1281GE
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history